| ASRAX | CSFZX | ASRAX / CSFZX | |
| Total Expense Ratio | 1.26 | 0.84 | 150% |
| Annual Report Gross Expense Ratio | 1.26 | 0.84 | 150% |
| Fund Existence | 24 years | 12 years | - |
| Gain YTD | 11.362 | 10.660 | 107% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 354M | 2.38B | 15% |
| Annual Yield % from dividends | 2.37 | 3.16 | 75% |
| Returns for 1 year | 12.96 | 12.41 | 104% |
| Returns for 3 years | 28.56 | 36.59 | 78% |
| Returns for 5 years | 6.81 | 8.45 | 81% |
| Returns for 10 years | 32.41 | 49.22 | 66% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PJP | 130.03 | 1.14 | +0.89% |
| Invesco Pharmaceuticals ETF | |||
| CALF | 57.80 | 0.50 | +0.87% |
| Pacer US Small Cap Cash Cows 100 ETF | |||
| SEMI | 37.89 | N/A | +0.01% |
| Columbia Select Technology ETF | |||
| ANV | 25.39 | -0.07 | -0.27% |
| GraniteShares Autocallable NVDA ETF | |||
| CEE | 20.49 | -0.17 | -0.82% |
| Central and Eastern Europe Fund (The) | |||